Moderna seeks us approval for 94.1% effective vaccine. Help create a new generation of transformative medicines for patients.
PERU. Dulce Goria. 2011. Asheninka Indians. Alex Webb Fotos
Pfizer and moderna are applying to the u.s.
Vaccin covid usa moderna. The massachusetts biotech firm said it will ask the food and drug administration for emergency use authorization after completing its phase 3 trial, finding the vaccine was 94.1 percent. On 16 april, barda made a us$483 million investment in the vaccine developer, moderna and its. The results come hot on the heels of similar results from pfizer, and add to growing.
Results from another 56 participants. The company will also apply for conditional approval from the european medicines agency, which is already reviewing the data. The coronavirus vaccine was found to be highly effective and showed no safety issues.
Vaccine candidates from pfizer and its german partner biontech, an… Moderna developed its vaccine in record time: Shares rose as much as 21% after the company said the u.s.
In a press release on monday it stated, “with today’s positive interim. A vaccine against this pandemic virus. Moderna will submit its coronavirus vaccine for regulatory approval on monday, the company said — the second leading drug to pass the milestone this month.
Karen weintraub, usa today 11/16/2020 Moderna is proud to be among the many groups working to respond to this continuing global health emergency. 'this makes me giddy,' one doctor says.